Centre Hospitalier William Morey
- Address
- lock Available on a paid plan
Centre Hospitalier William Morey - Oncology and Hematology Research
Centre Hospitalier William Morey is a distinguished medical research institution with extensive expertise in oncology and hematology. The center participates in cutting-edge clinical trials focusing on advanced cancer therapies and blood disorders, particularly in the development of precision medicine approaches and novel treatment combinations for both solid tumors and hematological malignancies.
- Multiple Myeloma: Comprehensive research in newly diagnosed and relapsed disease, including targeted therapies with daratumumab, lenalidomide, elranatamab, and isatuximab combinations
- Colorectal Cancer: Advanced studies utilizing circulating tumor DNA (ctDNA) for treatment decisions and investigating chemotherapy regimens with bevacizumab in metastatic settings
- Breast Cancer: Hormone receptor-positive disease research focusing on CDK4/6 inhibitors, endocrine therapy optimization, and ESR1 mutation detection strategies
- Autoimmune and Hematological Disorders: Investigation of anticoagulation strategies in autoimmune hemolytic anemia and immunotherapy approaches for ICU-acquired immunosuppression
The center demonstrates particular strength in personalized medicine approaches, including MRD (minimal residual disease) monitoring and ctDNA-guided treatment strategies. Additional research areas include endometrial cancer immunotherapy, metastatic renal cell carcinoma, cardiovascular disease prevention with colchicine, and infectious disease management including early syphilis treatment and HPV vaccine efficacy studies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 9 therapeutic areas and 15 of 68 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 68 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier William Morey
lock Showing 1 of 24 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Non-Inferiority Trial of Doxycycline Monohydrate Versus Benzathine Benzylpenicillin for the Treatment of Early Syphilis | Assistance Publique Hopitaux De Paris | Phase III | Not Recruiting | Dec 2021 | Jul 2025 |
IMP list
lock Showing 1 of 68 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 4 | Unknown | 2019-10-07 | 2025-07-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.